REGIONAL AND STRUCTURAL CHANGES OF THE SPINAL CORD TISSUE ENCOUNTERED IN AMYOTROPHIC LATERAL SCLEROSIS (ALS): A PRELIMINARY AND PROMISING CHARACTERIZATION USING DTI and ihMT.
Henitsoa Rasoanandrianina1,2,3,4, Aude-Marie Grapperon5, Manuel Taso1,2,3,4, Olivier M. Girard1,2, Guillaume Duhamel1,2, Elisabeth Soulier1,2, Lauriane Pini1,2, Audrey Rico6, Bertrand Audoin6, Maxime Guye1,2, Jean-Philippe Ranjeva1,2, and Virginie Callot1,2,3

1CRMBM UMR 7339, Aix-Marseille Université, CNRS, Marseille, France, 2CEMEREM, AP-HM, Pôle d'Imagerie Médicale, Hopital de La Timone, Marseille, France, 3iLab-Spine International Associate Laboratory, Marseille/Montréal, France, 4LBA UMR T 24, Aix-Marseille Université, IFSTTAR, Marseille, France, 5Service de Neurologie et Maladies neuro-musculaires, AP-HM,Hopital de La Timone, Marseille, France, 6Service de Neurologie et Unité NeuroVasculaire, AP-HM,Hopital de La Timone, Marseille, France

Synopsis

In this study, regional alteration of the spinal cord (SC) tissue encountered in amyotrophic lateral sclerosis (ALS) were investigated using dedicated SC templates and 3T-multiparametric MRI techniques, in particular diffusion tensor imaging (DTI) and the emerging myelin-specific inhomogeneous magnetization transfer (ihMT) technique. Results collected on 9 patients showed significant alteration of the DTI metrics compared to age-matched controls. They also demonstrated impairment of the MT metrics in the bilateral corticospinal tracts, as well as in the dorsal sensory tracts and the anterior gray matter horns. Combined with reduced ihMT metric variations, this suggests increase of the macromolecular pool, without pronounced demyelination. The structural changes we observed suggest a complex chrono-physiopathology that need to be further investigated.

Target audience

MRI researchers, neuroscientists and clinicians involved in research on amyotrophic lateral sclerosis (ALS) and degenerative spinal cord (SC) MR imaging.

Introduction

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by a progressive alteration, dysfunction and death of both upper and lower motor neurons. Its diagnosis is based on clinical and electrophysiological criteria, but multi-parametric MRI may also be helpful to provide information about the degree of tissue degradation. Cerebral white and gray matter (WM/GM) involvement, although not yet fully understood, have already been largely described using structural MRI[1, 2]. However, few SC descriptions have been given so far, mainly due to technical limitations related to the small size of the cord and physiological motion. In this study, we used DTI and the emerging myelin-specific inhomogeneous magnetization transfer imaging technique (ihMT)[3, 4] to assess structural changes occurring within specific SC regions of interest. Correlations with disease severity evaluated by the revised ALS functional rating scale (ALSFRS-R) were also investigated.

Material and Methods

MR explorations: 9 patients with ALS (56±8yo, ALSFRS-R=37.0±5.8) and 9 age-matched healthy controls (HC, 55±8yo) were scanned at 3T using commercial RF coils and a multi-parametric MR protocol consisting in anatomical, diffusion, and inhomogeneous MT acquisitions (cf. Fig.1 for sequence parameters). Two patients with progressive Multiple Sclerosis (MS) (53±7yo, EDSS=5.0±1.4), for which primary demyelination is expected, were additionally included as preliminary controls to study the specificity of our MR parameters.

Post-processing relied on the SC Toolbox [5], probabilistic atlases [6-8] and a customized MATLAB pipeline allowing specific processing for ihMT SC data [9] and automatic metrics extraction within bilateral corticospinal tracts (CST), posterior sensitive tracts (SP), and anterior gray matter horns (aGM) (Fig.2). Statistical analysis was conducted to compare the metrics obtained in ALS and HC groups. MS patients were not yet considered for statistics (n=2).

Clinical scores for ALS included ALSFRS-R, grip strength, Medical Research Council (MRC) Scale and Upper Motor Neuron (UMN) score [10].

Results

Representative multi-parametric maps collected on patients and controls are illustrated on Fig.3. When analyzing metrics extracted at each level within each ROI, significant structural differences were found in ALS compared to HC. Distribution for the main diffusivities, MT and ihMT are summarized in Fig.4. Interestingly, elevated $$$\lambda_{\bot}$$$ and MTR were observed, with moderate ihMTR decrease, suggesting destructuration and increase of the macromolecular pool, without pronounced demyelination. Statistical differences were also observed for FA (decrease, mainly in the CST) and ADC (increase, mainly in GM) (data not shown), most probably as a consequence of an increased $$$\lambda_{\bot}$$$.

Correlations of MR metrics with clinical scores were also observed (i) in the CST for $$$\lambda_{\bot}$$$, $$$\lambda_{//}$$$,FA and MTR at C2, and for $$$\lambda_{\bot}$$$ C5; (ii) in the SP for all DTI metrics and MTR; and (iii) for almost all metrics in the aGM at C5. Moreover, MTR values, initially higher than those of HCs, seemed to decrease with duration of the disease, suggesting a multi-phasic evolution with preliminary axonal impairment followed by installation of a demyelinating process (decrease of ihMTR, cf. Fig.5). However, no strong correlation could yet support this observation.

Finally, considering the preliminary results extracted from the 2 MS patients, DTI metrics were altered, although not significantly, with the same trend as for ALS patients. Most importantly, the ihMTR was lower by at least 13% (p<0.05) in the whole SC at both levels, all ROI considered, suggesting an important diffuse demyelination of WM tracts.

Discussion / Conclusion

Altogether, the DTI, MT and ihMT metrics in ALS patients showed significant SC structural changes consistent with ALS pathophysiology, not only in the CST [11-14] and the SP tracts [15], but also in the aGM horns (where motoneuron death is expected). The variations observed in the MTR and ihMTR also seem to reinforce the literature: the alteration observed in MS patients is consistent with the primary demyelination in MS pathophysiology, and tendency of alteration in ALS patients suggestive of a secondary demyelination process.

Although not yet possible due to low statistical power, one could possibly hypothesize that a multivariate analysis combining the different and complementary parameters collected in this study will give new insights into the pathology and lead to a better characterization of the spatio-temporal SC neurodegeneration and stratification of patients (Fig.5). For that purpose, further inclusions and ideally patient follow-ups will be conducted using both multi-parametric MR and atlas-based approaches. Further methodological developments will also be conducted so as to be able to investigate multiple SC levels within an acceptable scan time, and to fully exploit the contrast mechanism provided by the ihMT technique [3, 9].

Acknowledgements

No acknowledgement found.

References

[1] Turner, M.R., et al. Lancet Neurol, 2009. 8(1): p. 94-109. [2] Sage, C.A., et al. Neuroimage, 2007. 34(2): p. 486-99. [3] Varma, G., et al. Magn Reson Med, 2015. 73(2): p. 614-22. [4] Girard, O.M., et al. Magn Reson Med, 2015. 73(6): p. 2111-21. [5] Cohen-Adad, J., et al. Proceedings of the 20th annual meeting of OHBM. 2014. Hamburg, Germany. [6] Fonov, V.S., et al. Neuroimage, 2014. 102P2: p. 817-827. [7] Levy, S., et al. Neuroimage, 2015. 119(0): p. 262-271. [8] Taso, M., et al. Neuroimage, 2015. 117: p. 20-28. [9] Girard, O.M., et al. Proceedings of the ISMRM, Milan, Italy: 2014, p 3450. [10] Grapperon, A.M., et al. Muscle Nerve, 2014. 49(4): p. 551-7. [11] Terao, S., et al. Rinsho shinkeigaku = Clinical neurology, 1994. 34(9): p. 865-9. [12] Terao, S., et al. Journal of the neurological sciences, 1995. 133(1-2): p. 66-72. [13] Abe, K., et al. J Neuroimaging, 1997. 7(4): p. 208-12. [14] Agosta, F., et al. J Neurol Neurosurg Psychiatry, 2009. 80(1): p. 53-5. [15] Nair, G., et al. Neuroimage, 2010. 53(2): p. 576-83. [16] Cohen-Adad, J. Amyotroph Lateral Scler Frontotemporal Degener, 2013. 14(1): p. 30-8.

Figures

Fig.1: Main MR parameters used in this study.

Fig.2: Spinal cord templates [6, 7] and coregistration within patient’s T2*-w MR.

Fig.3: Characteristic multi-parametric maps of a healthy control (left), an ALS patient (middle, ALSFRS-R=30) with altered FA, increased MTR and moderately altered ihMT and a MS patient (right, EDSS=6) with altered FA, MTR and ihMT in relation with primary demyelination.

Fig.4: MR metrics obtained for ALS and HC subjects in specific ROIs, at both C2 and C5 levels. When existing, statistical differences (* p<0.05, ** <0.01, ***<0.001,two-sample t-test) and significant % of variations as compared to healthy controls are indicated.

Fig.5: MR metrics obtained for a random healthy control (left) and two representative ALS patients: ALS1 (middle, ALSFRS-R=30, disease duration 16 months) with altered MTR and moderately altered FA and ihMTR, and ALS2 (right, ALSFRS-R=41, disease duration 41 months) with altered FA and ihMTR, and moderately altered MTR.



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
1500